Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 (4 Bromophenyl)piperidine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113461597A reveals a cost-effective photoredox/Ni dual catalytic route for nilapanib intermediates, offering significant supply chain stability and reduced manufacturing costs.
Novel copper-catalyzed route for (S)-3-(4-bromophenyl)piperidine avoids azides and enzymes, offering cost-effective pharma intermediate manufacturing.